Related Experiment Video
Updated: Sep 23, 2025

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
Are H1-Antihistamines Associated With a Lower Risk of Hepatocellular Carcinoma?
Cho-Han Chiang1, Cho-Hsien Chiang1, Cho-Hung Chiang1
1Cho-Han Chiang, MD, Harvard Medical School, Boston, MA; Cho-Hsien Chiang, MD, London School of Hygiene & Tropical Medicine, London, UK; and Cho-Hung Chiang, MD, Division of General Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Foundation, New Taipei City, Taiwan.
No abstract available in PubMed .
Related Concept Videos
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Cholinergic Antagonists: Pharmacokinetics
Physical Properties of Amines
Hazard Ratio
For example, in a clinical trial...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

